Bioactive Compounds and Their Influence on Postnatal Neurogenesis

Mattova, Simona; Simko, Patrik; Urbanska, Nicol; Kiskova, Terezia

doi:10.3390/ijms242316614

Cited by 3 publications

(1 citation statement)

References 130 publications

(163 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, neurogenesis of NSPCs in the adult central nervous system (CNS) plays an important role in the repair of CNS injury and the recovery of neurodegeneration, and also becomes a potential therapeutic application for nerve injury and neurodegenerative diseases [4][5][6]. Recently, accumulating evidence has demonstrated that inducing neurogenesis of adult neural stem cells in vivo by drugs is an effective strategy for the treatment of nerve injury and neurodegenerative diseases [7][8][9]. Metformin, a commonly used diabetes drug, can promote neurogenesis in adult NSPCs and enhance spatial memory formation in mice [10].…”

Section: Introductionmentioning

confidence: 99%

A Acylhydrazone Compound A5 Promotes Neurogenesis by Up-regulating Neurogenesis-related Genes and Inhibiting Cell-cycle Progression in Neural Stem/Progenitor Cells

Xiang,

Jiang,

Lin

et al. 2024

Preprint

View full text Add to dashboard Cite

Adult neurogenesis involves generation of functional neurons from neural progenitor cells, which have the potential to complement and restore damaged neurons and neural circuits. Therefore, the development of drugs that stimulate neurogenesis represents a promising strategy in stem cell therapy and neural regeneration, greatly facilitating the reconstruction of neural circuits in cases of neurodegeneration and brain injury. Our study reveals that compound A5, previously designed and synthesized by our team, exhibits remarkable neuritogenic activities, effectively inducing neurogenesis in neural stem/progenitor cells (NSPCs). Subsequently, transcriptome analysis using high-throughput Illumina RNA-seq technology was performed to further elucidate the underlying molecular mechanisms by which compound A5 promotes neurogenesis. Notably, comparative transcriptome analysis showed that the up-regulated genes were mainly associated with neurogenesis and the down-regulated genes were mainly concerned with cell cycle progression. Furthermore, we confirmed that compound A5 significantly affected the expression of transcription factors related to neurogenesis and cell cycle regulatory proteins. Collectively, these findings identify a new compound with neurogenic activity and may provide insights into drug discovery for neural repair and regeneration.

show abstract

Section: Introductionmentioning

confidence: 99%

A Acylhydrazone Compound A5 Promotes Neurogenesis by Up-regulating Neurogenesis-related Genes and Inhibiting Cell-cycle Progression in Neural Stem/Progenitor Cells

Xiang,

Jiang,

Lin

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

Chib,

Dutta,

Chalotra

et al. 2024

Phytotherapy Research

View full text Add to dashboard Cite

With the passage of time, people step toward old age and become more prone to several diseases associated with the age. One such is Alzheimer's disease (AD) which results into neuronal damage and dementia with the progression of age. The existing therapeutics has been hindered by various enkindles like less eminent between remote populations, affordability issues and toxicity profiles. Moreover, lack of suitable therapeutic option further worsens the quality of life in older population. Developing an efficient therapeutic intervention to cure AD is still a challenge for medical fraternity. Recently, alternative approaches attain the attention of researchers to focus on plant‐based therapy in mitigating AD. In this context, flavonoids gained centrality as a feasible treatment in modifying various neurological deficits. This review mainly focuses on the pathological facets and economic burden of AD. Furthermore, we have explored the possible mechanism of flavonoids with the preclinical and clinical aspects for curing AD. Flavonoids being potential therapeutic, target the pathogenic factors of AD such as oxidative stress, inflammation, metal toxicity, Aβ accumulation, modulate neurotransmission and insulin signaling. In this review, we emphasized on potential neuroprotective effects of flavonoids in AD pathology, with focus on both experimental and clinical findings. While preclinical studies suggest promising therapeutic benefits, clinical data remains limited and inconclusive. Thus, further high‐quality clinical trials are necessary to validate the efficacy of flavonoids in AD. The study aim is to promote the plant‐based therapies and encourage people to add flavonoids to regular diet to avail the beneficial effects in preventive therapy for AD.

show abstract

Acylhydrazone Derivative A5 Promotes Neurogenesis by Up-Regulating Neurogenesis-Related Genes and Inhibiting Cell-Cycle Progression in Neural Stem/Progenitor Cells

Xiang,

Jiang,

Lin

et al. 2024

Molecules

View full text Add to dashboard Cite

Adult neurogenesis involves the generation of functional neurons from neural progenitor cells, which have the potential to complement and restore damaged neurons and neural circuits. Therefore, the development of drugs that stimulate neurogenesis represents a promising strategy in stem cell therapy and neural regeneration, greatly facilitating the reconstruction of neural circuits in cases of neurodegeneration and brain injury. Our study reveals that compound A5, previously designed and synthesized by our team, exhibits remarkable neuritogenic activities, effectively inducing neurogenesis in neural stem/progenitor cells (NSPCs). Subsequently, transcriptome analysis using high-throughput Illumina RNA-seq technology was performed to further elucidate the underlying molecular mechanisms by which Compound A5 promotes neurogenesis. Notably, comparative transcriptome analysis showed that the up-regulated genes were mainly associated with neurogenesis, and the down-regulated genes were mainly concerned with cell cycle progression. Furthermore, we confirmed that Compound A5 significantly affected the expression of transcription factors related to neurogenesis and cell cycle regulatory proteins. Collectively, these findings identify a new compound with neurogenic activity and may provide insights into drug discovery for neural repair and regeneration.

show abstract

Bioactive Compounds and Their Influence on Postnatal Neurogenesis

Cited by 3 publications

References 130 publications

A Acylhydrazone Compound A5 Promotes Neurogenesis by Up-regulating Neurogenesis-related Genes and Inhibiting Cell-cycle Progression in Neural Stem/Progenitor Cells

A Acylhydrazone Compound A5 Promotes Neurogenesis by Up-regulating Neurogenesis-related Genes and Inhibiting Cell-cycle Progression in Neural Stem/Progenitor Cells

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

Acylhydrazone Derivative A5 Promotes Neurogenesis by Up-Regulating Neurogenesis-Related Genes and Inhibiting Cell-Cycle Progression in Neural Stem/Progenitor Cells

Contact Info

Product

Resources

About